(Q70146789)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

D D Von Hoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S J Green

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J A Neidhart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

C Fabian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

T Budd

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J F Boyd

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

C K Osborne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

87-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2026487%20AND%20SRC:MED&resulttype=core&format=json

A phase II study of alanosine in advanced large bowel carcinoma

9 October 2019

cites work

1 reference

12 December 2020

The treatment of acute leukemia with continuous infusion L-Alanosine.

1 reference

12 December 2020

Alanosine, a new antiviral and antitumour agent isolated from a Streptomyces

1 reference

12 December 2020

Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanoma

1 reference

12 December 2020

Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancer.

1 reference

12 December 2020

Identifiers

1 reference